Daniel N. Swisher JR - 03 Mar 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
President and COO
Signature
By: /s/Adam Guttmann, as attorney in fact For: Daniel Newell Swisher
Issuer symbol
JAZZ
Transactions as of
03 Mar 2023
Transactions value $
-$774,724
Form type
4
Filing time
07 Mar 2023, 20:26:21 UTC
Previous filing
07 Dec 2022
Next filing
23 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +13.5K +28.64% $0.00 60.4K 03 Mar 2023 Direct F1
transaction JAZZ Ordinary Shares Tax liability -$775K -5.43K -8.98% $142.78 55K 05 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
F2 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.